SGEP Citations (12)

Originally described in: An optimized microRNA backbone for effective single-copy RNAi.
Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, Lai DY, Barbosa IA, Kwon JS, Guan Y, Sinha N, Zuber J Cell Rep. 2013 Dec 26;5(6):1704-13. doi: 10.1016/j.celrep.2013.11.020. Epub 2013 Dec 12. PubMed Journal

---

Articles Citing SGEP

Articles
Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia. Kiehlmeier S, Rafiee MR, Bakr A, Mika J, Kruse S, Muller J, Schweiggert S, Herrmann C, Sigismondo G, Schmezer P, Krijgsveld J, Groschel S. Leukemia. 2021 Apr 28. pii: 10.1038/s41375-021-01235-z. doi: 10.1038/s41375-021-01235-z. PubMed
Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis. Diesch J, Le Pannerer MM, Winkler R, Casquero R, Muhar M, van der Garde M, Maher M, Herraez CM, Bech-Serra JJ, Fellner M, Rathert P, Brooks N, Zamora L, Gentilella A, de la Torre C, Zuber J, Gotze KS, Buschbeck M. Nat Commun. 2021 Oct 18;12(1):6060. doi: 10.1038/s41467-021-26258-z. PubMed
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Smith AE, Ferraro E, Safonov A, Morales CB, Lahuerta EJA, Li Q, Kulick A, Ross D, Solit DB, de Stanchina E, Reis-Filho J, Rosen N, Arribas J, Razavi P, Chandarlapaty S. Nat Commun. 2021 Nov 18;12(1):6667. doi: 10.1038/s41467-021-27093-y. PubMed
Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21. Zhang CR, Ostrander EL, Kukhar O, Mallaney C, Sun J, Haussler E, Celik H, Koh WK, King KY, Gontarz P, Challen GA. Blood Cancer Discov. 2022 May 5;3(3):220-239. doi: 10.1158/2643-3230.BCD-21-0132. PubMed
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate. Funasaki S, Mehanna S, Ma W, Nishizawa H, Kamikubo Y, Sugiyama H, Ikeda S, Motoshima T, Hasumi H, Linehan WM, Schmidt LS, Ricketts C, Suda T, Oike Y, Kamba T, Baba M. Cancer Sci. 2022 Jul;113(7):2352-2367. doi: 10.1111/cas.15364. Epub 2022 May 4. PubMed
NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness. Wilkens AB, Fulton E, Pont MJ, Cole GO, Leung I, Stull SM, Hart MR, Bernstein ID, Furlan SN, Riddell SR. Blood. 2022 May 23. pii: 485320. doi: 10.1182/blood.2021015144. PubMed
Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications. Bagchi A, Devaraju N, Chambayil K, Rajendiran V, Venkatesan V, Sayed N, Pai AA, Nath A, David E, Nakamura Y, Balasubramanian P, Srivastava A, Thangavel S, Mohankumar KM, Velayudhan SR. Sci Rep. 2022 Aug 18;12(1):14033. doi: 10.1038/s41598-022-13783-0. PubMed
Taz protects hematopoietic stem cells from an aging-dependent decrease in PU.1 activity. Kim KM, Mura-Meszaros A, Tollot M, Krishnan MS, Grundl M, Neubert L, Groth M, Rodriguez-Fraticelli A, Svendsen AF, Campaner S, Andreas N, Kamradt T, Hoffmann S, Camargo FD, Heidel FH, Bystrykh LV, de Haan G, von Eyss B. Nat Commun. 2022 Sep 3;13(1):5187. doi: 10.1038/s41467-022-32970-1. PubMed
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity. Chen HA, Ho YJ, Mezzadra R, Adrover JM, Smolkin R, Zhu C, Woess K, Bernstein N, Schmitt G, Fong L, Luan W, Wuest A, Tian S, Li X, Broderick C, Hendrickson RC, Egeblad M, Chen Z, Alonso-Curbelo D, Lowe SW. Cancer Discov. 2023 Feb 6;13(2):432-453. doi: 10.1158/2159-8290.CD-22-0528. PubMed
A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. Yoo HB, Moon JW, Kim HR, Lee HS, Miyabayashi K, Park CH, Ge S, Zhang A, Tae YK, Sub Y, Park HW, Gee HY, Notta F, Tuveson DA, Bang S, Kim MY, Roe JS. Gastroenterology. 2023 Jul;165(1):133-148.e17. doi: 10.1053/j.gastro.2023.02.049. Epub 2023 Mar 11. PubMed
ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma. Mahieu CI, Mancini AG, Vikram EP, Planells-Palop V, Joseph NM, Tward AD. Mol Cancer Res. 2024 Feb 1;22(2):152-168. doi: 10.1158/1541-7786.MCR-23-0746. PubMed
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state. Xiao M, Kondo S, Nomura M, Kato S, Nishimura K, Zang W, Zhang Y, Akashi T, Viny A, Shigehiro T, Ikawa T, Yamazaki H, Fukumoto M, Tanaka A, Hayashi Y, Koike Y, Aoyama Y, Ito H, Nishikawa H, Kitamura T, Kanai A, Yokoyama A, Fujiwara T, Goyama S, Noguchi H, Lee SC, Toyoda A, Hinohara K, Abdel-Wahab O, Inoue D. Nat Commun. 2023 Dec 15;14(1):8372. doi: 10.1038/s41467-023-44081-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.